15
Participants
Start Date
October 15, 2025
Primary Completion Date
September 30, 2026
Study Completion Date
October 31, 2026
Peroneal Nerve Stimulation (PNS) Device
The TOMAC™ system is a non-invasive, wearable peroneal nerve stimulator that delivers high-frequency electrical stimulation to the common peroneal nerves at the fibular head. It is FDA-cleared for the treatment of moderate-to-severe Restless Legs Syndrome (RLS) in adults but has not been studied in pregnancy. In this trial, pregnant participants will undergo an in-clinic titration session with uterine contraction and fetal monitoring at ≥28 weeks' gestation to determine comfortable therapeutic intensity. They will then use the device at home for 8 weeks, up to four 30-minute sessions daily, prioritizing periods of high symptom burden or before bedtime. Outcomes will assess feasibility, acceptability, adherence, symptom improvement, sleep quality, and maternal-fetal safety.
NOT_YET_RECRUITING
Rhode Island Hospital, Providence
RECRUITING
Rhode Island Hospital, Providence
American College of Chest Physicians
OTHER
Rhode Island Hospital
OTHER